Interleukin Inhibitors Market Insights The  global interleukin inhibitors market size  is estimated at USD 36.36 billion in 2025 and is projected to reach USD 153.09 billion by 2034, growing at a CAGR of 17.36% during the forecast period. The global Interleukin Inhibitors Market is experiencing significant momentum, fueled by the growing prevalence of autoimmune and inflammatory diseases, coupled with rapid advancements in biologic therapies. Interleukin inhibitors, which target specific cytokines responsible for immune system signaling, have emerged as a cornerstone in the treatment of chronic conditions such as rheumatoid arthritis, psoriasis, asthma, and inflammatory bowel disease (IBD). The increasing adoption of precision medicine and targeted biologics is further accelerating market expansion, as healthcare providers shift toward more effective and personalized treatment modalities. Market Definition and Latest Trends Interleukin inhibitors are a...